INmune Bio, Inc. (INMB)

INmune Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.92	35.85	52.15	74.81	21.97
Cash & Short-Term Investments	20.92	35.85	52.15	74.81	21.97
Cash Growth	-41.64%	-31.26%	-30.29%	240.56%	214.02%
Other Receivables	1.41	2.44	8.46	5.5	1.8
Receivables	1.41	2.44	8.46	5.5	1.8
Prepaid Expenses	0.33	1.65	4.06	2.29	0.22
Total Current Assets	22.66	39.94	64.68	82.61	23.99
Property, Plant & Equipment	0.31	0.41	0.51	0.73	0.16
Other Intangible Assets	16.51	16.51	16.51	16.51	16.51
Other Long-Term Assets	0.08	0.13	0.1	0.1	-
Total Assets	39.56	57	81.8	99.95	40.66
Accounts Payable	6.54	7.9	5.21	3.8	1.52
Accrued Expenses	0.03	0.04	0.01	0.01	0.03
Current Portion of Long-Term Debt	-	9.92	5	-	-
Current Portion of Leases	0.14	0.12	0.09	0.07	0.03
Other Current Liabilities	0.52	0.49	0.62	0.47	0.19
Total Current Liabilities	7.22	18.47	10.92	4.36	1.78
Long-Term Debt	-	-	9.7	14.46	-
Long-Term Leases	0.24	0.4	0.53	0.7	0.13
Other Long-Term Liabilities	-	-	0.55	0.2	-
Total Liabilities	7.47	18.86	21.69	19.72	1.9
Common Stock	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	195.75	159.14	151.8	143.92	72.11
Retained Earnings	-163.1	-121.02	-91.01	-63.72	-33.38
Comprehensive Income & Other	-0.58	-0.8	-0.7	0	0.01
Total Common Equity	32.1	37.34	60.1	80.23	38.75
Shareholders' Equity	32.1	38.14	60.1	80.23	38.75
Total Liabilities & Equity	39.56	57	81.8	99.95	40.66
Total Debt	0.38	10.44	15.31	15.23	0.16
Net Cash (Debt)	20.54	25.41	36.84	59.58	21.81
Net Cash Growth	-19.18%	-31.03%	-38.16%	173.20%	219.42%
Net Cash Per Share	1.03	1.41	2.06	3.69	1.82
Filing Date Shares Outstanding	22.93	17.95	17.95	17.86	14.93
Total Common Shares Outstanding	22.28	17.95	17.95	17.84	13.48
Working Capital	15.44	21.48	53.76	78.25	22.21
Book Value Per Share	1.44	2.08	3.35	4.50	2.87
Tangible Book Value	15.58	20.83	43.59	63.71	22.24
Tangible Book Value Per Share	0.70	1.16	2.43	3.57	1.65

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q